A general IGF-I overexpression effectively rescued somatic growth and bone deficiency in mice caused by growth hormone receptor knockout

References

• Bachrach LK, Marcus R, Ott SM, Rosenbloom AL, Vasconez O, Martinez V, Martinez AL, Rosenfeld RG, Guevara-Aguirre J. 1998. Bone mineral, histomorphometry, and body composition in adults with growth hormone receptor deficiency. J Bone Miner Res. 13:415–421.
   PubMed Web of Science ®Google Scholar
• Behringer RR, Lewin TM, Quaife CJ, Palmiter RD, Brinster RL, D'Ercole AJ. 1990. Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice. Endocrinology. 127:1033–1040.
   PubMed Web of Science ®Google Scholar
• Chernausek SD, Backeljauw PF, Frane J, Kuntze J, Underwood LE, and for the GHISCG. 2007. Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity. J Clin Endocrinol Metab. 92:902–910.
   PubMed Web of Science ®Google Scholar
• Duan C, Xu Q. 2005. Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. Gen Comp Endocrinol. 142:44–52.
   PubMed Web of Science ®Google Scholar
• Kaplan SA, Cohen P. 2007. Review: The somatomedin hypothesis 2007: 50 years later. J Clin Endocrinol Metab. 92:4529–4535.
   PubMed Web of Science ®Google Scholar
• Kim H, Barton E, Muja N, Yakar S, Pennisi P, Leroith D. 2005. Intact insulin and insulin-like growth factor-I receptor signaling is required for growth hormone effects on skeletal muscle growth and function in vivo. Endocrinology. 146:1772–1779.
   PubMed Web of Science ®Google Scholar
• Laron Z, Ginsberg S, Lilos P, Arbiv M, Vaisman N. 2006. Long-term IGF-I treatment of children with Laron syndrome increases adiposity. Growth Horm IGF Res. 16:61–64.
   PubMed Web of Science ®Google Scholar
• Le Roith D, Bondy C, Yakar S, Liu J-L, Butler A. 2001. The somatomedin hypothesis: 2001. Endocr Rev. 22:53–74.
   PubMed Web of Science ®Google Scholar
• Liu JL, LeRoith D. 1999. Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology. 140:5178–5184.
   PubMed Web of Science ®Google Scholar
• Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 75:59–72.
   PubMed Web of Science ®Google Scholar
• Liu JL, Yakar S, LeRoith D. 2000. Mice deficient in liver production of insulin-like growth factor I display sexual dimorphism in growth hormone-stimulated postnatal growth. Endocrinology. 141:4436–4441.
   PubMed Web of Science ®Google Scholar
• Liu JL, Coschigano KT, Robertson K, Lipsett M, Guo Y, Kopchick JJ, Kumar U, Liu YL. 2004. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am J Physiol Endocrinol Metab. 287:E405–E413.
   PubMedGoogle Scholar
• Mathews LS, Hammer RE, Behringer RR, D'Ercole AJ, Bell GI, Brinster RL, Palmiter RD. 1988. Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology. 123:2827–2833.
   PubMed Web of Science ®Google Scholar
• Norrelund H. 2005. The metabolic role of growth hormone in humans with particular reference to fasting. Growth Horm IGF Res. 15:95–122.
   PubMed Web of Science ®Google Scholar
• Ohneda K, Ulshen MH, Fuller CR, D'Ercole AJ, Lund PK. 1997. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I. Gastroenterology. 112:444–454.
   PubMed Web of Science ®Google Scholar
• Pescovitz OH, Eugster EA. 2004. Pediatric endocrinology: Mechanisms, manifestations, and management. Philadelphia, PA: Lippincott.
   Google Scholar
• Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA. 1993. IGF-I is required for normal embryonic growth in mice. Genes Dev. 7:2609–2617.
   PubMed Web of Science ®Google Scholar
• Robertson K, Kopchick JJ, Liu JL. 2006. Growth hormone receptor gene deficiency causes delayed insulin responsiveness in skeletal muscles without affecting compensatory islet cell overgrowth in obese mice. Am J Physiol Endocrinol Metab. 291:E491–E498.
   Web of Science ®Google Scholar
• Robertson K, Lu Y, De Jesus K, Li B, Su Q, Lund PK, Liu JL. 2008. A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes. Am J Physiol Endocrinol Metab. 294:E928–E938.
   Web of Science ®Google Scholar
• Sims NA, Clement-Lacroix P, Da Ponte F, Bouali Y, Binart N, Moriggl R, Goffin V, Coschigano K, Gaillard-Kelly M, Kopchick J, Baron R, Kelly PA. 2000. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest. 106:1095–1103.
   PubMed Web of Science ®Google Scholar
• Sjogren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson OG, Jansson JO, Ohlsson C. 1999. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA. 96:7088–7092.
   PubMed Web of Science ®Google Scholar
• Sjogren K, Bohlooly YM, Olsson B, Coschigano K, Tornell J, Mohan S, Isaksson OG, Baumann G, Kopchick J, Ohlsson C. 2000. Disproportional skeletal growth and markedly decreased bone mineral content in growth hormone receptor − / − mice. Biochem Biophys Res Commun. 267:603–608.
   PubMed Web of Science ®Google Scholar
• Stratikopoulos E, Szabolcs M, Dragatsis I, Klinakis A, Efstratiadis A. 2008. The hormonal action of IGF1 in postnatal mouse growth. Proc Natl Acad Sci USA. 105:19378–19383.
   PubMed Web of Science ®Google Scholar
• Wallenius K, Sjogren K, Peng X-D, Park S, Wallenius V, Liu J-L, Umaerus M, Wennbo H, Isaksson O, Frohman L, Kineman R, Ohlsson C, Jansson J-O, Liver-derived IGF-I, regulates GH. 2001. secretion at the pituitary level in mice. Endocrinology. 142:4762–4770.
   PubMed Web of Science ®Google Scholar
• Wu Y, Sun H, Yakar S, Leroith D. 2009. Elevated levels of IGF-1 in serum rescue the severe growth retardation of IGF-1 null mice. 150 9: 4395–4403 Endocrinology.
   Google Scholar
• Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D. 1999. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA. 96:7324–7329.
   PubMed Web of Science ®Google Scholar
• Ye P, Carson J, D'Ercole AJ. 1995. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. Journal of Neuroscience. 15:7344–7356.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K, Wagner TE, Baumann G, Kopchick JJ. 1997. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA. 94:13215–13220.
   PubMed Web of Science ®Google Scholar